STOCK TITAN
  1. Home
  2. News
  3. REGN

Regeneron Pharmaceuticals, Inc. - REGN STOCK NEWS

IMPACT
SENTIMENT
REGN : Nasdaq
Regeneron Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference
IMPACT
SENTIMENT
REGN : Nasdaq SNY : Nasdaq
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP for the Treatment of Eosinophilic Esophagitis
IMPACT
SENTIMENT
REGN : Nasdaq SNY : Nasdaq
Dupixent® (dupilumab) Approved by European Commission as the First and Only Targeted Medicine Indicated for Prurigo Nodularis
IMPACT
SENTIMENT
REGN : Nasdaq
Odronextamab (CD20xCD3) Demonstrates High and Durable Complete Response Rate among Patients with Relapsed/Refractory Follicular Lymphoma in Pivotal Phase 2 Trial
clinical trial
IMPACT
SENTIMENT
REGN : Nasdaq
Linvoseltamab (BCMAxCD3) Initial Pivotal Phase 2 Data Show Clinically Meaningful Responses in Patients with Heavily Pre-treated Multiple Myeloma
clinical trial
IMPACT
SENTIMENT
REGN : Nasdaq
Regeneron Named on Dow Jones Sustainability World Index for Fourth Consecutive Year
IMPACT
SENTIMENT
REGN : Nasdaq
Pivotal Odronextamab (CD20xCD3) Phase 2 Data in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Debut at ASH
clinical trial
IMPACT
SENTIMENT
REGN : Nasdaq
Regeneron ESMO IO Presentations Highlight Potential of Fianlimab and Libtayo® (cemiplimab) in Multiple Solid Tumor Types
IMPACT
SENTIMENT
REGN : Nasdaq
Evkeeza® (evinacumab-dgnb) sBLA for Children with Ultra-rare Inherited Form of High Cholesterol Accepted for FDA Priority Review
IMPACT
SENTIMENT
REGN : Nasdaq
Libtayo® (cemiplimab) Approved by the European Commission as the First Immunotherapy in Second Line Recurrent or Metastatic Cervical Cancer Irrespective of PD-L1 Expression Level or Tumor Histology
Stock REGN logo
Regeneron Pharmaceuticals, Inc.

Nasdaq:REGN

REGN Rankings

#141 Ranked by Market Cap
#1795 Ranked by Stock Gains
N/A Ranked by Dividends

REGN Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Tarrytown

About REGN

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.